U.S. flag

An official website of the United States government

NM_003482.4(KMT2D):c.5993A>G (p.Tyr1998Cys) AND Kabuki syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Oct 22, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003588758.2

Allele description [Variation Report for NM_003482.4(KMT2D):c.5993A>G (p.Tyr1998Cys)]

NM_003482.4(KMT2D):c.5993A>G (p.Tyr1998Cys)

Gene:
KMT2D:lysine methyltransferase 2D [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
12q13.12
Genomic location:
Preferred name:
NM_003482.4(KMT2D):c.5993A>G (p.Tyr1998Cys)
HGVS:
  • NC_000012.12:g.49042205T>C
  • NG_027827.1:g.18120A>G
  • NM_003482.4:c.5993A>GMANE SELECT
  • NP_003473.3:p.Tyr1998Cys
  • NC_000012.11:g.49435988T>C
  • NM_003482.3:c.5993A>G
Protein change:
Y1998C
Links:
dbSNP: rs1292951816
NCBI 1000 Genomes Browser:
rs1292951816
Molecular consequence:
  • NM_003482.4:c.5993A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Kabuki syndrome
Synonyms:
Kabuki make-up syndrome; Niikawa-Kuroki syndrome
Identifiers:
MONDO: MONDO:0016512; MedGen: C0796004; OMIM: PS147920

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004295040Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Oct 22, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Immunologic assessment and KMT2D mutation detection in Kabuki syndrome.

Lin JL, Lee WI, Huang JL, Chen PK, Chan KC, Lo LJ, You YJ, Shih YF, Tseng TY, Wu MC.

Clin Genet. 2015 Sep;88(3):255-60. doi: 10.1111/cge.12484. Epub 2014 Oct 14.

PubMed [citation]
PMID:
25142838

A comparative analysis of KMT2D missense variants in Kabuki syndrome, cancers and the general population.

Faundes V, Malone G, Newman WG, Banka S.

J Hum Genet. 2019 Feb;64(2):161-170. doi: 10.1038/s10038-018-0536-6. Epub 2018 Nov 20.

PubMed [citation]
PMID:
30459467
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004295040.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 1998 of the KMT2D protein (p.Tyr1998Cys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with Kabuki syndrome (PMID: 25142838, 30459467). ClinVar contains an entry for this variant (Variation ID: 1303257). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on KMT2D protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024